Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 138

1.

Appropriate Use Criteria in Dermatopathology: Initial Recommendations from the American Society of Dermatopathology.

Vidal CI, Armbrect EA, Andea AA, Bohlke AK, Comfere NI, Hughes SR, Kim J, Kozel JA, Lee JB, Linos K, Litzner BR, Missall TA, Novoa RA, Sundram U, Swick BL, Hurley MY, Alam M, Argenyi Z, Duncan LM, Elston DM, Emanuel PO, Ferringer T, Fung MA, Hosler GA, Lazar AJ, Lowe L, Plaza JA, Prieto VG, Robinson JK, Schaffer A, Subtil A, Wang WL.

J Am Acad Dermatol. 2018 Apr 21. pii: S0190-9622(18)30632-7. doi: 10.1016/j.jaad.2018.04.033. [Epub ahead of print]

PMID:
29689323
2.

Contrasting features of childhood and adolescent melanomas.

Bartenstein DW, Kelleher CM, Friedmann AM, Duncan LM, Tsao H, Sober AJ, Hawryluk EB.

Pediatr Dermatol. 2018 May;35(3):354-360. doi: 10.1111/pde.13454. Epub 2018 Mar 23.

PMID:
29569376
3.

Appropriate use criteria in dermatopathology: Initial recommendations from the American Society of Dermatopathology.

Vidal CI, Armbrect EA, Andea AA, Bohlke AK, Comfere NI, Hughes SR, Kim J, Kozel JA, Lee JB, Linos K, Litzner BR, Missall TA, Novoa RA, Sundram U, Swick BL, Hurley MY, Alam M, Argenyi Z, Duncan LM, Elston DM, Emanuel PO, Ferringer T, Fung MA, Hosler GA, Lazar AJ, Lowe L, Plaza JA, Prieto VG, Robinson JK, Schaffer A, Subtil A, Wang WL.

J Cutan Pathol. 2018 Aug;45(8):563-580. doi: 10.1111/cup.13142. Epub 2018 Jun 7.

PMID:
29566273
4.

Resistance to checkpoint blockade therapy through inactivation of antigen presentation.

Sade-Feldman M, Jiao YJ, Chen JH, Rooney MS, Barzily-Rokni M, Eliane JP, Bjorgaard SL, Hammond MR, Vitzthum H, Blackmon SM, Frederick DT, Hazar-Rethinam M, Nadres BA, Van Seventer EE, Shukla SA, Yizhak K, Ray JP, Rosebrock D, Livitz D, Adalsteinsson V, Getz G, Duncan LM, Li B, Corcoran RB, Lawrence DP, Stemmer-Rachamimov A, Boland GM, Landau DA, Flaherty KT, Sullivan RJ, Hacohen N.

Nat Commun. 2017 Oct 26;8(1):1136. doi: 10.1038/s41467-017-01062-w.

5.

Differential UBE2C and HOXA1 expression in melanocytic nevi and melanoma.

Kraft S, Moore JB, Muzikansky A, Scott KL, Duncan LM.

J Cutan Pathol. 2017 Oct;44(10):843-850. doi: 10.1111/cup.12997. Epub 2017 Jul 21.

PMID:
28657121
6.

Lymphatic invasion predicts sentinel lymph node metastasis and adverse outcome in primary cutaneous melanoma.

Moy AP, Mochel MC, Muzikansky A, Duncan LM, Kraft S.

J Cutan Pathol. 2017 Sep;44(9):734-739. doi: 10.1111/cup.12969. Epub 2017 Jun 19.

PMID:
28555886
7.

IgG4 Expression in Primary Cutaneous Marginal Zone Lymphoma: A Multicenter Study.

De Souza A, Ferry JA, Burghart DR, Tinguely M, Goyal A, Duncan LM, Kutzner H, Kempf W.

Appl Immunohistochem Mol Morphol. 2017 Feb 1. doi: 10.1097/PAI.0000000000000462. [Epub ahead of print]

PMID:
28151793
8.

Differential Expression of Hedgehog and Snail in Cutaneous Fibrosing Disorders: Implications for Targeted Inhibition.

Goyal A, Linskey KR, Kay J, Duncan LM, Nazarian RM.

Am J Clin Pathol. 2016 Dec;146(6):709-717. doi: 10.1093/ajcp/aqw192.

PMID:
28077400
9.

Lymphatic invasion and angiotropism in primary cutaneous melanoma.

Moy AP, Duncan LM, Kraft S.

Lab Invest. 2017 Feb;97(2):118-129. doi: 10.1038/labinvest.2016.131. Epub 2016 Dec 19.

10.

Heterogeneity of Metastatic Melanoma:  Correlation of MITF With Its Transcriptional Targets MLSN1, PEDF, HMB-45, and MART-1.

Zand S, Buzney E, Duncan LM, Dadras SS.

Am J Clin Pathol. 2016 Sep;146(3):353-60. doi: 10.1093/ajcp/aqw115. Epub 2016 Aug 11.

PMID:
27515936
11.

A Symmetric Eczematous Eruption Harboring Thousands of Melanocytic Lesions.

Ratushny V, Kraft S, Moschella SL, Duncan LM, Lawrence DP, Tsao H.

JAMA Dermatol. 2016 Sep 1;152(9):1021-4. doi: 10.1001/jamadermatol.2016.1150.

PMID:
27192392
12.

Evaluation of the Melanocytic Pathology Assessment Tool and Hierarchy for Diagnosis (MPATH-Dx) classification scheme for diagnosis of cutaneous melanocytic neoplasms: Results from the International Melanoma Pathology Study Group.

Lott JP, Elmore JG, Zhao GA, Knezevich SR, Frederick PD, Reisch LM, Chu EY, Cook MG, Duncan LM, Elenitsas R, Gerami P, Landman G, Lowe L, Messina JL, Mihm MC, van den Oord JJ, Rabkin MS, Schmidt B, Shea CR, Yun SJ, Xu GX, Piepkorn MW, Elder DE, Barnhill RL; International Melanoma Pathology Study Group.

J Am Acad Dermatol. 2016 Aug;75(2):356-63. doi: 10.1016/j.jaad.2016.04.052. Epub 2016 May 14.

13.

Cytokeratin 17 is highly sensitive in discriminating cutaneous lymphadenoma (a distinct trichoblastoma variant) from basal cell carcinoma.

Goyal A, Solus JF, Chan MP, Doyle LA, Schaffer A, Thakuria M, Horn TD, Duncan LM, Nazarian RM.

J Cutan Pathol. 2016 May;43(5):422-9. doi: 10.1111/cup.12700. Epub 2016 Apr 6.

PMID:
26968559
14.

Corrigendum to "Eruptive inflamed seborrheic keratoses in the setting of endometrial adenocarcinoma" [International Journal of Women's Dermatology 1 (2015) 155-156].

Storer M, Duncan LM, Kourosh AS.

Int J Womens Dermatol. 2015 Oct 27;1(4):195. doi: 10.1016/j.ijwd.2015.10.001. eCollection 2015 Dec.

15.

Eruptive inflamed seborrheic keratoses in the setting of endometrial adenocarcinoma.

Storer M, Duncan LM, Kourosh AS.

Int J Womens Dermatol. 2015 Sep 14;1(3):155-156. doi: 10.1016/j.ijwd.2015.07.003. eCollection 2015 Aug. Erratum in: Int J Womens Dermatol. 2015 Oct 27;1(4):195.

16.

Increased NY-ESO-1 expression and reduced infiltrating CD3+ T cells in cutaneous melanoma.

Giavina-Bianchi M, Giavina-Bianchi P, Sotto MN, Muzikansky A, Kalil J, Festa-Neto C, Duncan LM.

J Immunol Res. 2015;2015:761378. doi: 10.1155/2015/761378. Epub 2015 Apr 14.

17.

Contribution of longitudinal follow up and clinical pathological correlation in the diagnosis CD30-positive skin infiltrates.

De Souza A, Carter JB, Harris NL, Ferry JA, Duncan LM.

J Cutan Pathol. 2015 Jul;42(7):452-8. doi: 10.1111/cup.12510. Epub 2015 Jun 4.

PMID:
25931140
18.

Clinical significance of microscopic melanoma metastases in the nonhottest sentinel lymph nodes.

Luo S, Lobo AZ, Tanabe KK, Muzikansky A, Durazzo T, Sober A, Tsao H, Cosimi AB, Lawrence DP, Duncan LM.

JAMA Surg. 2015 May;150(5):465-72. doi: 10.1001/jamasurg.2014.3843.

PMID:
25831227
19.

Immunologic Overlap of Helper T-Cell Subtypes 17 and 22 in Erythrodermic Psoriasis and Atopic Dermatitis.

Moy AP, Murali M, Kroshinsky D, Duncan LM, Nazarian RM.

JAMA Dermatol. 2015 Jul;151(7):753-60. doi: 10.1001/jamadermatol.2015.2.

PMID:
25760640
20.

Granulomatous reaction to liquid injectable silicone for gluteal enhancement: review of management options and success of doxycycline.

Paul S, Goyal A, Duncan LM, Smith GP.

Dermatol Ther. 2015 Mar-Apr;28(2):98-101. doi: 10.1111/dth.12204. Epub 2015 Feb 3. Review.

PMID:
25649644
21.

Delivering value in dermatology: insights from skin cancer detection in routine clinical visits.

Enamandram M, Duncan LM, Kimball AB.

J Am Acad Dermatol. 2015 Feb;72(2):310-3. doi: 10.1016/j.jaad.2014.10.030. Epub 2014 Dec 4.

PMID:
25484266
22.

Outcome of patients with de novo versus nevus-associated melanoma.

Lin WM, Luo S, Muzikansky A, Lobo AZ, Tanabe KK, Sober AJ, Cosimi AB, Tsao H, Duncan LM.

J Am Acad Dermatol. 2015 Jan;72(1):54-8. doi: 10.1016/j.jaad.2014.09.028. Epub 2014 Oct 18.

PMID:
25440436
23.

Interinstitutional whole slide imaging teleconsultation service development: assessment using internal training and clinical consultation cases.

Jones NC, Nazarian RM, Duncan LM, Kamionek M, Lauwers GY, Tambouret RH, Wu CL, Nielsen GP, Brachtel EF, Mark EJ, Sadow PM, Grabbe JP, Wilbur DC.

Arch Pathol Lab Med. 2015 May;139(5):627-35. doi: 10.5858/arpa.2014-0133-OA. Epub 2014 Nov 21.

PMID:
25415180
24.

PD-1, S-100 and CD1a expression in pseudolymphomatous folliculitis, primary cutaneous marginal zone B-cell lymphoma (MALT lymphoma) and cutaneous lymphoid hyperplasia.

Goyal A, Moore JB, Gimbel D, Carter JB, Kroshinsky D, Ferry JA, Harris NL, Duncan LM.

J Cutan Pathol. 2015 Jan;42(1):6-15. doi: 10.1111/cup.12440. Epub 2014 Dec 11.

PMID:
25384543
25.

Primary mucosal melanoma of the sinonasal tract: a clinicopathologic and immunohistochemical study of thirty-two cases.

Mochel MC, Duncan LM, Piris A, Kraft S.

Head Neck Pathol. 2015 Jun;9(2):236-43. doi: 10.1007/s12105-014-0570-4. Epub 2014 Oct 8.

26.

Basaloid Carcinoma of the Breast Mimicking Cutaneous Basaloid Neoplasms.

Solus JF, Goyal A, Duncan LM, Nazarian RM.

Am J Dermatopathol. 2015 Sep;37(9):e102-6. doi: 10.1097/DAD.0000000000000209.

PMID:
25229570
27.

Case records of the Massachusetts General Hospital. Case 23-2014. A 41-year-old man with fevers, rash, pancytopenia, and abnormal liver function.

Hay CM, Shepard JA, Hyle EP, Duncan LM.

N Engl J Med. 2014 Jul 24;371(4):358-66. doi: 10.1056/NEJMcpc1404140. No abstract available.

PMID:
25054720
28.

Atypical Spitz tumours and sentinel lymph nodes.

Duncan LM.

Lancet Oncol. 2014 Apr;15(4):377-8. doi: 10.1016/S1470-2045(13)70397-8. No abstract available.

PMID:
24694629
29.

Histomorphologic assessment and interobserver diagnostic reproducibility of atypical spitzoid melanocytic neoplasms with long-term follow-up.

Gerami P, Busam K, Cochran A, Cook MG, Duncan LM, Elder DE, Fullen DR, Guitart J, LeBoit PE, Mihm MC Jr, Prieto VG, Rabkin MS, Scolyer RA, Xu X, Yun SJ, Obregon R, Yazdan P, Cooper C, Weitner BB, Rademaker A, Barnhill RL.

Am J Surg Pathol. 2014 Jul;38(7):934-40. doi: 10.1097/PAS.0000000000000198.

PMID:
24618612
30.

Cytokeratin 17: an adjunctive marker of invasion in squamous neoplastic lesions of the anus.

Nazarian RM, Primiani A, Doyle LA, Linskey KR, Duncan LM, Odze RD, Zukerberg LR.

Am J Surg Pathol. 2014 Jan;38(1):78-85. doi: 10.1097/PAS.0000000000000111.

PMID:
24335642
31.

Haploid genetic screens identify an essential role for PLP2 in the downregulation of novel plasma membrane targets by viral E3 ubiquitin ligases.

Timms RT, Duncan LM, Tchasovnikarova IA, Antrobus R, Smith DL, Dougan G, Weekes MP, Lehner PJ.

PLoS Pathog. 2013;9(11):e1003772. doi: 10.1371/journal.ppat.1003772. Epub 2013 Nov 21.

32.

Aleukemic cutaneous myeloid sarcoma.

Aboutalebi A, Korman JB, Sohani AR, Hasserjian RP, Louissaint A Jr, Le L, Kraft S, Duncan LM, Nazarian RM.

J Cutan Pathol. 2013 Dec;40(12):996-1005. doi: 10.1111/cup.12231. Epub 2013 Oct 8.

PMID:
24274424
33.

Lack of standards for the detection of melanoma in sentinel lymph nodes: a survey and recommendations.

Dekker J, Duncan LM.

Arch Pathol Lab Med. 2013 Nov;137(11):1603-9. doi: 10.5858/arpa.2012-0550-OA.

PMID:
24168497
34.

BerEp4, cytokeratin 14, and cytokeratin 17 immunohistochemical staining aid in differentiation of basaloid squamous cell carcinoma from basal cell carcinoma with squamous metaplasia.

Linskey KR, Gimbel DC, Zukerberg LR, Duncan LM, Sadow PM, Nazarian RM.

Arch Pathol Lab Med. 2013 Nov;137(11):1591-8. doi: 10.5858/arpa.2012-0424-OA.

PMID:
24168496
35.

MicroRNA-mediated loss of ADAR1 in metastatic melanoma promotes tumor growth.

Nemlich Y, Greenberg E, Ortenberg R, Besser MJ, Barshack I, Jacob-Hirsch J, Jacoby E, Eyal E, Rivkin L, Prieto VG, Chakravarti N, Duncan LM, Kallenberg DM, Galun E, Bennett DC, Amariglio N, Bar-Eli M, Schachter J, Rechavi G, Markel G.

J Clin Invest. 2013 Jun;123(6):2703-18.

36.

MERTK receptor tyrosine kinase is a therapeutic target in melanoma.

Schlegel J, Sambade MJ, Sather S, Moschos SJ, Tan AC, Winges A, DeRyckere D, Carson CC, Trembath DG, Tentler JJ, Eckhardt SG, Kuan PF, Hamilton RL, Duncan LM, Miller CR, Nikolaishvili-Feinberg N, Midkiff BR, Liu J, Zhang W, Yang C, Wang X, Frye SV, Earp HS, Shields JM, Graham DK.

J Clin Invest. 2013 May;123(5):2257-67. doi: 10.1172/JCI67816. Epub 2013 Apr 15.

37.

HIF1α and HIF2α independently activate SRC to promote melanoma metastases.

Hanna SC, Krishnan B, Bailey ST, Moschos SJ, Kuan PF, Shimamura T, Osborne LD, Siegel MB, Duncan LM, O'Brien ET 3rd, Superfine R, Miller CR, Simon MC, Wong KK, Kim WY.

J Clin Invest. 2013 May;123(5):2078-93. doi: 10.1172/JCI66715. Epub 2013 Apr 8.

38.

BCL2A1 is a lineage-specific antiapoptotic melanoma oncogene that confers resistance to BRAF inhibition.

Haq R, Yokoyama S, Hawryluk EB, Jönsson GB, Frederick DT, McHenry K, Porter D, Tran TN, Love KT, Langer R, Anderson DG, Garraway LA, Duncan LM, Morton DL, Hoon DS, Wargo JA, Song JS, Fisher DE.

Proc Natl Acad Sci U S A. 2013 Mar 12;110(11):4321-6. doi: 10.1073/pnas.1205575110. Epub 2013 Feb 27.

39.

Tapasin-related protein TAPBPR is an additional component of the MHC class I presentation pathway.

Boyle LH, Hermann C, Boname JM, Porter KM, Patel PA, Burr ML, Duncan LM, Harbour ME, Rhodes DA, Skjødt K, Lehner PJ, Trowsdale J.

Proc Natl Acad Sci U S A. 2013 Feb 26;110(9):3465-70. doi: 10.1073/pnas.1222342110. Epub 2013 Feb 11.

40.

Subcutaneous Sweet syndrome in the setting of myeloid disorders: a case series and review of the literature.

Chan MP, Duncan LM, Nazarian RM.

J Am Acad Dermatol. 2013 Jun;68(6):1006-15. doi: 10.1016/j.jaad.2012.12.954. Epub 2013 Feb 8. Review.

PMID:
23399459
41.

Wolf isotopic response manifesting as postherpetic granuloma annulare: a case series.

Kapoor R, Piris A, Saavedra AP, Duncan LM, Nazarian RM.

Arch Pathol Lab Med. 2013 Feb;137(2):255-8. doi: 10.5858/arpa.2011-0643-OA.

PMID:
23368868
42.

The distribution of microscopic melanoma metastases in sentinel lymph nodes: implications for pathology protocols.

Lobo AZ, Tanabe KK, Luo S, Muzikansky A, Sober AJ, Tsao H, Cosimi AB, Duncan LM.

Am J Surg Pathol. 2012 Dec;36(12):1841-8. doi: 10.1097/PAS.0b013e31826d25f9.

PMID:
23154770
43.

Fibrosis-associated single-nucleotide polymorphisms in TGFB1 and CAV1 are not associated with the development of nephrogenic systemic fibrosis.

Le LP, Garibyan L, Lara D, Finberg KE, Iafrate AJ, Duncan LM, Kay J, Nazarian RM.

Am J Dermatopathol. 2013 May;35(3):351-6. doi: 10.1097/DAD.0b013e31826c5508.

PMID:
23051628
44.

Importance of glycolysis and oxidative phosphorylation in advanced melanoma.

Ho J, de Moura MB, Lin Y, Vincent G, Thorne S, Duncan LM, Hui-Min L, Kirkwood JM, Becker D, Van Houten B, Moschos SJ.

Mol Cancer. 2012 Oct 9;11:76. doi: 10.1186/1476-4598-11-76.

45.

Melanoma staging: where are we now?

Piris A, Lobo AC, Duncan LM.

Dermatol Clin. 2012 Oct;30(4):581-92, v. doi: 10.1016/j.det.2012.06.001. Epub 2012 Jul 31. Review.

PMID:
23021047
46.

Loss of 5-hydroxymethylcytosine is an epigenetic hallmark of melanoma.

Lian CG, Xu Y, Ceol C, Wu F, Larson A, Dresser K, Xu W, Tan L, Hu Y, Zhan Q, Lee CW, Hu D, Lian BQ, Kleffel S, Yang Y, Neiswender J, Khorasani AJ, Fang R, Lezcano C, Duncan LM, Scolyer RA, Thompson JF, Kakavand H, Houvras Y, Zon LI, Mihm MC Jr, Kaiser UB, Schatton T, Woda BA, Murphy GF, Shi YG.

Cell. 2012 Sep 14;150(6):1135-46. doi: 10.1016/j.cell.2012.07.033.

47.

Sentinel lymph node metastasis is not predictive of poor outcome in patients with problematic spitzoid melanocytic tumors.

Hung T, Piris A, Lobo A, Mihm MC Jr, Sober AJ, Tsao H, Tanabe KK, Duncan LM.

Hum Pathol. 2013 Jan;44(1):87-94. doi: 10.1016/j.humpath.2012.04.019. Epub 2012 Aug 30.

PMID:
22939951
48.

The RNA-binding E3 ubiquitin ligase MEX-3C links ubiquitination with MHC-I mRNA degradation.

Cano F, Bye H, Duncan LM, Buchet-Poyau K, Billaud M, Wills MR, Lehner PJ.

EMBO J. 2012 Aug 29;31(17):3596-606. doi: 10.1038/emboj.2012.218. Epub 2012 Aug 3.

49.

Fluorescence-based phenotypic selection allows forward genetic screens in haploid human cells.

Duncan LM, Timms RT, Zavodszky E, Cano F, Dougan G, Randow F, Lehner PJ.

PLoS One. 2012;7(6):e39651. doi: 10.1371/journal.pone.0039651. Epub 2012 Jun 22.

50.

Germline BAP1 inactivation is preferentially associated with metastatic ocular melanoma and cutaneous-ocular melanoma families.

Njauw CN, Kim I, Piris A, Gabree M, Taylor M, Lane AM, DeAngelis MM, Gragoudas E, Duncan LM, Tsao H.

PLoS One. 2012;7(4):e35295. doi: 10.1371/journal.pone.0035295. Epub 2012 Apr 24.

Supplemental Content

Loading ...
Support Center